Grand View Research, Inc. - Market Research And Consulting.According to report published by Grand View Research,The global radiation oncology market size is expected to reach USD 10.1 billion by 2025. It is projected to witness a CAGR of 6.5% over the forecast period. Rising prevalence of cancer is the primary factor responsible for substantial growth of the market for radiation oncology.
The global radiation oncology market size is expected to reach USD 10.1 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to witness a CAGR of 6.5% over the forecast period. Rising prevalence of cancer is the primary factor responsible for substantial growth of the market for radiation oncology.
Technological advancements resulted in increased adoption of radiation oncology as primary cancer treatment. Development of compact advanced radiotherapy options such as CyberKnife, Gamma Knife, and tomotherapy are expected to complement this growth. These advanced methods pose lesser postoperative complications and faster recovery time.
Increasing per capita healthcare expenditure is also an important macroeconomic factor driving market growth. In addition, with the aid of supportive government initiatives and awareness, patients are not hesitant to opt for advanced treatment options. For instance, per capita health expenditure witnessed exponential growth of more than 55.0% from 1995 to 2014, as stated by the World Bank Group.
Full Research Report On Radiation Oncology Market Analysis:
www.grandviewresearch.com/industry-analysis/radiation-oncology-market
Further key findings from the study suggest:
In 2016, external beam radiation therapy (EBRT) inclusive of compact advanced radiation therapy, proton therapy, and linear accelerator (LINAC), held a lucrative share by product
Brachytherapy is likely to gain maximum share over the coming years owing to extensive usage for the treatment of prostate and breast cancer
EBRT applications for treatment of prostate, breast, lung, colorectal, head, and neck cancer dominated the market in 2016 by way of application
Image guided radiation therapy (IGRT) contributed to around 13.0% share in 2016 on the basis of technology. In this method, overall objective is to minimize the exposure to the healthy surrounding tissue
3D-CRT technology is anticipated to witness a lucrative CAGR over the forecast period
North America held maximum share in global radiation oncology market in 2016. Developed health infrastructure, presence of many multinational players, and high per capita health infrastructure are the key regional growth drivers
Varian Medical Systems; Elekta AB; Accuray Incorporated; Ion Beam Applications SA; C.R. Bard, Inc.; IsoRay, Inc.; Mevion Medical Systems, Nordion (Canada) Inc.; NTP; and Mallinckrodt Public Limited Company are some of the key market players
Browse More Reports Of This Category By Grand View Research At:
www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global radiation oncology market by product, application, technology, and region:
Radiation Oncology Product Outlook (Revenue, USD Million, 2014 - 2025)
External Beam Radiation Therapy
Electron-Emitting High-Energy Linear Accelerators (Linac)
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
Tomotherapy
Proton Therapy
Cyclotron
Synchrotron
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Beam Radiation Therapy
Others
Radiation Oncology Application Outlook (Revenue, USD Million, 2014 - 2025)
External Beam Radiation Therapy
Prostate Cancer
Breast Cancer
Lung Cancer
Head and Neck Cancer
Colorectal Cancer
Others
Internal Beam Radiation Therapy
Prostate Cancer
Gynecological Cancer
Breast Cancer
Cervical Cancer
Penile Cancer
Others
Radiation Oncology Technology Outlook (Volume, Units; Revenue, USD Million, 2014 - 2025)
External Beam Radiation Therapy
Image-Guided Radiotherapy (IGRT)
Intensity Modulated Radiotherapy (IMRT)
Stereotactic Technology
Proton Beam Therapy
3D Conformal Radiotherapy (3D CRT)
Volumetric Modulated Arc Therapy (VMAT)
Brachytherapy
Low-Dose Rate Brachytherapy
High-Dose Rate Brachytherapy
Systemic Beam Radiation Therapy
Others
Radiation Oncology Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
U.S.
Canada
Europe
Germany
U.K.
Asia Pacific
China
Japan
Latin America
Mexico
Brazil
Middle East & Africa
South Africa
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/radiation-oncology-market
Source: www.abnewswire.com